Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	114.35	354.73	92.65	45.68	43.46	79.67
Short-Term Investments	482.41	359.86	548.21	115.04	71.19	-
Cash & Short-Term Investments	596.76	714.59	640.85	160.72	114.65	79.67
Cash Growth	1.17%	11.51%	298.75%	40.18%	43.90%	48.50%
Other Current Assets	19.04	14.29	10.37	11.31	11.05	2.86
Total Current Assets	615.8	728.88	651.22	172.02	125.7	82.54
Net Property, Plant & Equipment	-	3.3	4.33	3.04	5.22	-
Long-Term Investments	-	-	-	-	0.06	0.87
Other Long-Term Assets	5.94	2.55	0.13	0.48	0.46	0.34
Total Assets	621.74	734.73	655.68	175.55	131.44	83.75
Accounts Payable	13.91	21.9	7.67	11.12	11.99	1.39
Accrued Expenses	31.24	31.01	16.22	8.75	10.96	5.93
Current Portion of Leases	-	0.55	1.48	2.44	2.65	-
Other Current Liabilities	-	-	-	-	-	0.38
Total Current Liabilities	45.15	53.46	25.37	22.3	25.6	7.69
Long-Term Debt	75.03	74.84	50.69	49.88	24.81	4.92
Long-Term Leases	1.86	1.92	2.47	1.4	3.83	-
Other Long-Term Liabilities	-	-	-	0.29	0.29	1.54
Total Long-Term Liabilities	76.89	76.76	53.16	51.56	28.93	6.47
Total Liabilities	122.04	130.21	78.53	73.86	54.53	14.16
Common Stock	0.07	0.07	0.06	0.04	0.03	0.02
Additional Paid-in Capital	1,382	1,365	1,038	410.49	290.22	193.63
Accumulated Other Comprehensive Income	-0.16	0.79	0.39	0.25	-0.22	-
Retained Earnings	-881.9	-760.87	-461.25	-309.1	-213.11	-124.06
Total Common Shareholders' Equity	499.7	604.52	577.16	101.69	76.91	69.59
Shareholders' Equity	499.7	604.52	577.16	101.69	76.91	69.59
Total Liabilities & Equity	621.74	734.73	655.68	175.55	131.44	83.75
Total Debt	76.89	77.31	54.64	53.71	31.29	4.92
Net Cash (Debt)	519.87	637.28	586.21	107.01	83.37	74.75
Net Cash Growth	-18.42%	8.71%	447.82%	28.36%	11.53%	39.32%
Net Cash Per Share	7.81	9.92	10.60	2.51	3.14	5.56
Book Value	499.7	604.52	577.16	101.69	76.91	69.59
Book Value Per Share	7.50	9.41	10.43	2.38	2.89	5.18
Tangible Book Value	499.7	604.52	577.16	101.69	76.91	69.59
Tangible Book Value Per Share	7.50	9.41	10.43	2.38	2.89	5.18

SEC Filings: 10-K · 10-Q